期刊文献+

晚期肿瘤并发呼吸道感染70例痰培养临床分析

Clinical analysis of sputum cultures in 70 patients with advanced tumors complicated with respiratory infection
下载PDF
导出
摘要 目的:探索晚期肿瘤患者并发呼吸道感染的特点。方法:针对不同的肿瘤患者,根据病情对口腔分泌物进行痰培养,检测并鉴定致病菌。70例患者中:男44例,女26例;年龄>60岁48例,50~60岁12例,<50岁10例。结果:晚期肿瘤患者并发呼吸道感染中G^-菌阳性率54.2%,G^+菌阳性率14.3%,真菌感染的阳性率为31.4%。结论:晚期肿瘤患者呼吸道较常见的感染致病菌种为真菌、肺炎克雷伯菌、鲍曼不动杆菌、大肠杆菌和铜绿假单胞杆菌,发病年龄主要集中在60岁以上男性患者。因此对于晚期肿瘤患者,应根据病情实时、正确留取标本,进行病原体检测并结合既往用药史,选择合理的治疗方案。 Objective : To study the features of microbes in respiratory infection patients with advanced tumors. Methods : Culture of sputum was taken from the mouth cavity in light of the condition of the patients for determining the pathogenic microbes. Of the 70 cases, 44 of them were male and 26, female. 48 cases aged more than 60 years, 12 ranged in age from 50 to 60 years and 10 were younger than 50 years. Results : In 70 advanced tumor patients complicated with respiratory infection, microbes of gram-negative bacilli were detected in 54.2% cases, grampositive in 14.3% cases and fungi infection in 31.4%, respectively. Conclusion: Most common pathogenic microbes that affect patients of advanced tumor with respiratory tract infection are fungi, Klebsiella pneumoniae, Acinetobacter baumannii, Escherichia coils and Pseudomonas, and the male patients aged 60 years and over are easily involved. Consequently, the treatment prescription has to be centered on the real condition, right examination of culture and pathogenic microorganism and past medication history.
作者 程静 李燕
出处 《皖南医学院学报》 CAS 2008年第2期121-122,共2页 Journal of Wannan Medical College
关键词 晚期肿瘤 感染 痰培养 advanced tumor infection sputum culture
  • 相关文献

参考文献3

二级参考文献10

  • 1National Committee for Clinical Laboratory Standard, 2002. Performance Standards for Antimicrobial Susceptibility Testing. NCCLS, Wayne, Pa.
  • 2Rhomberg PR, Jones RN , MYSTIC Study Group. Antimicrobial spectrum of activity for meropenem and nine broad spectrum antimicrobials:report from the MYSTIC Program (2002) in North America. Diagn Microbiol Infect Dis, 2003,47:365-372.
  • 3Pfaller MA, Jones RN , MYSTIC Study Group. Antimicrobial susceptibility of inducible Amp C β-lactamase-producing Enterobacteriaceae from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme, Europe 1997-2000. Int J Antimicrob Agents, 2002,19:383-388.
  • 4Sader HS, Biedenbach DJ ,Jones RN. Global patterns of susceptibility for 21 commonly utilized antimicrobial agents tested against 48440 Enterobacteriaceae in the SENTRY Antimicrobial Surveillance Program (1997-2000). Diagn Microbiol Infect Dis, 2003,47:361-364.
  • 5Sader HS, Gales AC, Pfaller MA, et al. Pathogen frequency and resistance patterns in Brazilian hospitals:summary of results from three years of the SENTRY Antimicrobial Surveillance Program. Braz J Infect Dis, 2001,5:200-214.
  • 6Devita VT Jr, Hellman S, Rosenberg SA. Cancer principai &amp; practice of oncology. 4th ed. Philadelphia: J.B. Lippncott Company, 1993: 2293- 2294
  • 7徐忠信 王枢群.肿瘤患者医院感染流行病学研究[J].中华流行病学杂志,1993,14(9):16-16.
  • 8李家泰,AllanJ Weinstein,杨敏,中国细菌耐药监测研究组.中国细菌耐药监测研究[J].中华医学杂志,2001,81(1):8-16. 被引量:376
  • 9文细毛,任南,徐秀华,黄勋.全国医院感染监控网医院感染病原菌分布及耐药性分析[J].中华医院感染学杂志,2002,12(4):241-244. 被引量:744
  • 10李家泰,李耘,王进,中国细菌耐药监测研究组.中国医院和社区获得性感染革兰阳性球菌耐药性监测研究[J].中华医学杂志,2003,83(5):365-374. 被引量:198

共引文献295

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部